Owkin, in partnership with Servier, is organizing a global AI hackathon to accelerate glioblastoma research. Over 100 experts will analyze patient data, including multi-omics and spatial...
In addition to the drug against brain tumors, Laminar has two other drugs licensed in phase two: one, developed together with Ability Pharma, against pancreatic cancer,...